Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 4.3% – What’s Next?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) fell 4.3% during mid-day trading on Wednesday . The company traded as low as $22.25 and last traded at $22.7725. 73,963 shares changed hands during trading, a decline of 71% from the average session volume of 253,948 shares. The stock had previously closed at $23.79.

Analyst Ratings Changes

Separately, Zacks Research lowered shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Stock Performance

The company has a quick ratio of 1.60, a current ratio of 2.31 and a debt-to-equity ratio of 0.06. The firm has a 50-day moving average price of $24.36 and a two-hundred day moving average price of $24.35. The firm has a market cap of $42.09 billion and a PE ratio of 20.96.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.